Management of adult acne and acne variants

Journal of Cutaneous Medicine and Surgery

Volumn 2, Issue SUPPL. 3, 1998, Pages

  Cunliffe, W J ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTI ACNE AGENT; ANTIBIOTIC AGENT; COTRIMOXAZOLE; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STEROID; TRIMETHOPRIM; ANTIINFECTIVE AGENT; KERATOLYTIC AGENT;

ACNE; ACNE CONGLOBATA; ACNE FULMINANS; CLINICAL FEATURE; FOLLICULITIS; GRAM NEGATIVE INFECTION; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; ROSACEA; SCAR; ACNE VULGARIS; ADULT; FEMALE; HYPERANDROGENISM; MALE; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PYODERMA; SEX DIFFERENCE;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; FOLLICULITIS; HUMANS; HYPERANDROGENISM; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; PYODERMA; SEX FACTORS;

EID: 0032057804     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136:66-70.
2. O'Loughlin M. Acne in the adult female. Aust J Dermatol 1964; 7:218-222.
3. Seukeran D, Cunliffe WJ. Acne vulgaris in the sixth decade. Br J Dermatol 1998; in press.
4. Darley CR, Kirby JD, Besser GM, et al. Circulating testosterone, sex hormone-binding globulin and prolactin in women with late onset or persistent acne vulgaris. Br J Dermatol 1982; 106: 517-522.
5. Bunker CB, Newton JA, Kilbom J, et al. Most women with acne have polycystic ovaries. Br J Dermatol 1989; 121:675-680.
6. Walton S, Cunliffe WJ, Keczkes K, et al. Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris. Br J Dermatol 1995; 133:249-253.
7. McLaughlin B, Barrett P, Finch T, et al. Late-onset adrenal hyperplasia in a group of Irish females who presented with hirsutism, irregular menses and/or cystic acne. Clin Endocrinol 1990; 32: 57-64.
8. Thiboutot D, Harris G, Iles V, et al. Activity of the type 1 5-alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995; 105:209-214.
9. Imperato-McGinley J, Gautier T, Cai-L-Q, et al. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 1993; 76:524-528.
10. Thiboutot DM, Knaggs H, Gilliland K, et al. Activity of type 1 5α-reductase is greater in the follicular infra-infundibulum compared with the epidermis. Br J Dermatol 1997; 136:166-171.
11. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol 1983; 109: 191-198.
12. Stewart ME, Wertz PW, Crahek MO. Relationship between sebum secretion rates and the concentration of linoleate in sebum and epidermal lipids. Clin Res 1985; 33:684-688.
13. Leerning JP, Holland KT, Cunliffe WJ. The pathological and ecological significance of microorganisms colonising acne vulgaris comedones. J Mol Microbiol 1985; 20:11-16.
14. Pochi PE, Shalita AR, Strauss JS, et al. Report of the Consensus Conference on Acne Classification, Washington DC. J Am Acad Dermatol 1991; 241:495-500.
15. Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993; 306:555-556.
16. Till A, Eady EA, Cunliffe WJ, et al. The microbiology of late-onset and persistent acne. J Invest Dermatol 1997; 108:380.
17. Motley RJ, Finaly AY. How much disability is caused by acne? Clin Exp Dermatol 1989; 14:194-198.
18. Koo J. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol 1995; 32:26-30.
19. Motley RJ, Finaly AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 16:1-13.
20. Eady EA, Cove JH, Joanes DN, et al. Topical antibiotics for the treatment of acne: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990; 1:215-216.
21. Stern RS. Acne therapy: medication use and sources of care in office-based practice. Arch Dermatol 1996; 132:776-780.
22. Gibson JR, Darley CR, Harvey SG, et al. Oral trimethoprim versus oxytetracycline in the treatment of inflammatory acne vulgaris. Br J Dermatol 1982; 107:221-224.
23. Hanstead B, Reymann F. Cyproterone acetate in the treatment of acne vulgaris in adult females. Dermatologica 1982; 164:117-126.
24. Goulden V, Layton AM, Cunliffe WJ. Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology 1995; 190:284-287.
25. Cunliffe WJ, van de Kerkhof, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194:351-357.
26. Harms M, Masooye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica 1986; 172:148-153.
27. Seukeran D, Lewis J, Cunliffe WJ. Oral isotretinoin is not associated with increased side effects when prescribed to patients with less severe acne. J Dermatol Treat 1998; in press.
28. Goulden V, Clark SM, Cunliffe WJ. Treatment of adult acne with low dose intermittent isotretinoin. Br J Dermatol 1996; 135:20.
29. Gregory A, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994; 130:319-324.
30. Hoting VE, Schutte B, Schirren C. Isotretinoin treatment of acne conglobata. Andrologic follow-up. Fortschr Med 1992; 110:427-430.
31. Gogler H. Surgical therapy of severe acne conglobata. Zentralbl Chir 1989; 114:840-843.
32. Waxman J, Rustin MH, Perry L, et al. Acne conglobata responding to buserelin, a gonadotrophin-releasing hormone analogue. Br J Dermatol 1983; 109:679-681.
33. Whipp MJ, Harrington CI, Dundas S. Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol 1987; 117:389-392.
34. Jeong S, Lee CW. Acne conglobata: treatment with isotretinoin, colchicine, and cyclosporin as compared with surgical intervention (letter). Clin Exp Dermatol 1996; 21:462-463.
35. Burns RE, Colville JM. Acne conglobata with septicemia. Arch Dermatol 1959; 79:361-363.
36. Kelly AP, Burns RE. Acute febrile ulcerative conglobata acne with polyarthralgia. Arch Dermatol 1971; 104:182-187.
37. Williamson DM, Cunliffe WJ, Gatecliff M, et al. Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum. Clin Exp Dermatol 1977; 2:351-354.
38. Kellett JK, Beck MH, Chalmers RJG. Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. BMJ 1985; 290:820.
39. Strom S, Thyresson N, Bostrom H. Acute febrile ulcerative conglobate acne with leukemoid reaction. Acta Derm Venereol (Stockh) 1973; 53:306-312.
40. Palatsi R. Delayed hypersensitivity and febrile acne conglobata. Acta Derm Venereol (Stockh) 1979; 59:157-160.
41. Karvonen SL, Rasanen L, Cunliffe WJ, et al. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans. Dermatology 1994; 189:344-349.
42. Karvonen S. Acne fulminans: report of clinical findings and treatment of twenty-four patients. J Am Acad Dermatol 1993; 28:572-579.
43. Fulton JE, McGinley K, Leyden J, et al. Gram-negative folliculitis in acne vulgaris. Arch Dermatol 1968; 98:349-353.
44. Plewig C, Nikolowski J, Wolff HH. Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol 1982; 6:766-785.
45. Poli F, Prost C, Revuz J. Folliculitis à bacilles Gram négatif. Ann Dermatol Venereol 1988; 115:797-800.
46. Leyden JJ, McGinley KJ, Mills OH. Pseudomonas aeruginosa gram-negative folliculitis. Arch Dermatol 1979; 115:1203-1204.
47. James WD, Leyden JJ. Treatment of gram-negative folliculitis with isotretinoin: positive clinical and microbiologic response. J Am Acad Dermatol 1985; 12:319-324.
48. O'Leary PA, Kierland RR. Pyoderma faciale. Arch Dermatol Syphilo 1940; 41:451-462.
49. Massa MC, Su WP. Pyoderma faciale: a clinical study of twenty-nine patients. J Am Acad Dermatol 1982; 6:84-91.
50. Plewig G, Jansen T, Kligman AM. Pyoderma faciale. A review and report of 20 additional cases; is it rosacea? Arch Dermatol 1992; 128:1611-1617.
51. Jansen T, Plewig G. An historical note on pyoderma faciale. Br J Dermatol 1993; 129:594-596.
52. Marks VJ, Briggaman RA. Pyoderma faciale: successful treatment with isotretinoin. J Am Acad Dermatol 1987; 17:1062-1063.
53. Woolfson H. Acne fulminans with circulating immune complexes and leukemoid reaction treated with steroids and azathioprine. Clin Exp Dermatol 1987; 12:463-466.